121 related articles for article (PubMed ID: 19470561)
1. Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients.
Suzuki Y; Watanabe J; Fukui N; Ozdemir V; Someya T
BMJ; 2009 May; 338():a1792. PubMed ID: 19470561
[No Abstract] [Full Text] [Related]
2. [Sexual disturbances during the treatment with neuroleptics in patients with schizophrenia and schizophrenia spectrum disorders].
Iagubov MI; Shtark LN
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):57-60. PubMed ID: 22027609
[TBL] [Abstract][Full Text] [Related]
3. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
4. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
[TBL] [Abstract][Full Text] [Related]
5. The new antipsychotic compounds: is a clinical choice algorithm possible?
Wirshing WC
West J Med; 1998 Jul; 169(1):43-4. PubMed ID: 9682633
[No Abstract] [Full Text] [Related]
6. Lessons to be learned from CATIE and CUtLASS.
Sutton BJ
Psychiatr Serv; 2008 May; 59(5):473. PubMed ID: 18450999
[No Abstract] [Full Text] [Related]
7. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
[TBL] [Abstract][Full Text] [Related]
8. Neutropenia associated with quetiapine, olanzapine, and aripiprazole.
Lander M; Bastiampillai T
Aust N Z J Psychiatry; 2011 Jan; 45(1):89. PubMed ID: 21058927
[No Abstract] [Full Text] [Related]
9. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
Lublin H; Haug HJ; Koponen H; Sigmundsson T; Kolb SA
World J Biol Psychiatry; 2009; 10(4 Pt 3):710-8. PubMed ID: 18803070
[TBL] [Abstract][Full Text] [Related]
12. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
13. Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
Sahoo S; Ameen S; Akhtar S
Aust N Z J Psychiatry; 2007 Jul; 41(7):629. PubMed ID: 17691161
[No Abstract] [Full Text] [Related]
14. [Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia].
Danilov DS
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):48-55. PubMed ID: 20517226
[TBL] [Abstract][Full Text] [Related]
15. Care maps: atypical antipsychotics. Introduction.
Houltram B; Scanlan M
Nurs Stand; 2004 May 19-25; 18(36):42-4. PubMed ID: 15176111
[No Abstract] [Full Text] [Related]
16. QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents.
de Castro MJ; Fraguas D; Laita P; Moreno D; Parellada M; Pascual D; Alvarez M; Merchán-Naranjo J; Rapado M; Giráldez M; Leiva M; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):381-3. PubMed ID: 18759648
[No Abstract] [Full Text] [Related]
17. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
Sacchetti E; Valsecchi P; Parrinello G;
Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
[TBL] [Abstract][Full Text] [Related]
19. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia.
Karagianis J; Williams R; Davis L; Procyshyn R; Monga N; Hanley J; Chandrasena R; Thakur A; Dickson R
Curr Med Res Opin; 2009 Sep; 25(9):2121-32. PubMed ID: 19601707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]